Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» PEN's 10-Y Financials

Financials (Next Earnings Date: 2017-02-28)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

PEN Guru Trades in Q1 2016

Chuck Royce 1,000 sh (unchged)
PRIMECAP Management 86,800 sh (-14.31%)
» More
Q2 2016

PEN Guru Trades in Q2 2016

Paul Tudor Jones 5,500 sh (New)
Jim Simons 158,600 sh (New)
Chuck Royce 1,000 sh (unchged)
PRIMECAP Management 84,600 sh (-2.53%)
» More
Q3 2016

PEN Guru Trades in Q3 2016

Steven Cohen 24,700 sh (New)
Pioneer Investments 58,492 sh (New)
Jim Simons 186,500 sh (+17.59%)
Chuck Royce 1,000 sh (unchged)
Paul Tudor Jones Sold Out
PRIMECAP Management 79,100 sh (-6.50%)
» More
Q4 2016

PEN Guru Trades in Q4 2016

Pioneer Investments 67,629 sh (+15.62%)
Chuck Royce 1,000 sh (unchged)
Steven Cohen Sold Out
Jim Simons Sold Out
PRIMECAP Management 66,000 sh (-16.56%)
» More
» Details

Insider Trades

Latest Guru Trades with PEN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339999    SIC: 3841
Compare:NAS:LIVN, NYSE:GMED, NAS:ZLTQ, NYSE:NVRO, NAS:WMGI, OTCPK:NHNKY, OTCPK:GGNDF, NAS:IART, OTCPK:EKTAY, NAS:CYNO, OTCPK:FSPKF, NAS:INGN, OTCPK:IOBCF, NAS:MASI, NAS:BABY, NAS:NUVA, NAS:CNMD, NAS:SPNC, NYSE:ITGR, NAS:VASC » details
Traded in other countries:0P8.Germany,
Penumbra Inc designs, develops, manufactures and markets medical devices. The products of the company address ischemic stroke, hemorrhagic stroke and vascular conditions that can be treated through thrombectomy and embolization procedures.

Penumbra Inc was incorporated in 2004 as a Delaware corporation under the name Penumbra. It is an interventional therapies company that designs, develops, manufactures and markets medical devices. The products of the company address ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. The Company sells its products to hospitals through its salesforce, as well as through distributors. It sells its products through direct sales organization in the United States, Europe, Canada and Australia. Its products include Penumbra System, ACE, Penumbra Coil 400, Penumbra SMART COIL, LIBERTY Stent, Apollo System, Ruby Coil and Indigo System. The Company competes with manufacturers and distributors of neurovascular and peripheral vascular medical devices. Its competitors are Boston Scientific, Johnson & Johnson, Medtronic, Stryker and Terumo. Its products are medical devices subject to extensive and ongoing regulation by the FDA under the Federal Food, Drug, and Cosmetic Act (FD&C Act), and its implementing regulations, as well as other federal and state regulatory bodies in the United States and comparable authorities in other countries under other statutes and regulations.

Ratios

vs
industry
vs
history

Buy Back

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history

More Statistics

Revenue (TTM) (Mil) $244.6
EPS (TTM) $ 0.05
Short Percentage of Float10.08%
52-Week Range $41.35 - 79.49
Shares Outstanding (Mil)31.64

Analyst Estimate

Dec16 Dec17 Dec18 Dec19
Revenue (Mil $) 258 314 370 435
EPS ($) -0.09 0.15 0.43 0.89
EPS w/o NRI ($) -0.09 0.15 0.43 0.89
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for PEN

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
Penumbra, Inc. Schedules Fourth Quarter and Full Year 2016 Earnings Release and Conference Call for... Feb 14 2017
Quest Diagnostics (DGX) Launches HBV Quantitative Test Jan 20 2017
Can The Uptrend Continue for Penumbra (PEN)? Jan 19 2017
Becton, Dickinson Commercially Launches Precise WTA Kits Jan 18 2017
Zacks.com featured highlights: Ollie's Bargain Outlet Holdings, Premier, Penumbra, DigitalGlobe and... Jan 17 2017
Medidata Solutions Clinical Cloud Gets Picked by Celgene Jan 17 2017
Pacific Biosciences (PACB) to Sell 10 PacBio Sequel Systems Jan 17 2017
VWR Buys SEASTAR CHEMICALS to Boost Americas Division Jan 17 2017
Akers Biosciences (AKER) Closes Offering of 1.7M Shares Jan 16 2017
Intuitive Surgical (ISRG) Expects Strong Revenues in Q4 Jan 13 2017
Henry Schein Hurt by Higher Costs, Lacks Growth Drivers Jan 12 2017
Illumina and Bio-Rad Unveil Single-Cell Sequencing Solution Jan 12 2017
NuVasive at 52-Week High on Preliminary Results, MHLW Nod Jan 12 2017
Luminex Projects Strong Q4 Revenues, Issues 2017 Guidance Jan 11 2017
DexCom Looking Forward to Strong Revenues in Q4 and 2016 Jan 11 2017
Teleflex Launches LMA Gastro Airway, FDA Okays Arrow VPS Jan 11 2017
PerkinElmer (PKI) to Acquire India-Based Tulip Diagnostics Jan 10 2017
Allscripts (MDRX) Q4 Bookings Likely to Hit Record Levels Jan 10 2017
Air Methods (AIRM): Winter Hits December Passenger Count Jan 09 2017
AngioDynamics (ANGO) Beats Q2 Earnings, Lifts 2017 View Jan 09 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)